The Riverside closure underscores a hard truth: resilience is not free. Maintaining onshore or near-shore manufacturing ...

Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...

With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...

Pharmaceutical Intermediates Market OverviewThe global pharmaceutical intermediates market is witnessing steady expansion as pharmaceutical manufacturing scales worldwide. Valued at approximately USD ...

ST. LOUIS--(BUSINESS WIRE)--The API Innovation Center (APIIC) today announced that it has been awarded funding by the Administration for Strategic Preparedness and Response’s (ASPR) Center for ...

Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.

Emzor Pharmaceutical Industries Limited, a leading pharmaceutical company in Nigeria, has announced a ground-breaking $230 million investment in a new Active Pharmaceutical Ingredients (API) ...

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-dependent ...